- Home
- PRTC vs FMAO Comparison
PRTC vs FMAO Comparison
Compare PRTC & FMAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTC
- FMAO
- Stock Information
- Founded
- PRTC 2015
- FMAO 1897
- Country
- PRTC United States
- FMAO United States
- Employees
- PRTC N/A
- FMAO N/A
- Industry
- PRTC Biotechnology: Pharmaceutical Preparations
- FMAO Savings Institutions
- Sector
- PRTC Health Care
- FMAO Finance
- Exchange
- PRTC Nasdaq
- FMAO Nasdaq
- Market Cap
- PRTC 413.5M
- FMAO 356.9M
- IPO Year
- PRTC N/A
- FMAO N/A
- Fundamental
- Price
- PRTC $18.01
- FMAO $24.51
- Analyst Decision
- PRTC Buy
- FMAO
- Analyst Count
- PRTC 1
- FMAO 0
- Target Price
- PRTC $45.00
- FMAO N/A
- AVG Volume (30 Days)
- PRTC 2.8K
- FMAO 22.9K
- Earning Date
- PRTC 08-27-2025
- FMAO 07-28-2025
- Dividend Yield
- PRTC N/A
- FMAO 3.61%
- EPS Growth
- PRTC N/A
- FMAO 38.39
- EPS
- PRTC 0.21
- FMAO 2.16
- Revenue
- PRTC $4,828,000.00
- FMAO $108,632,000.00
- Revenue This Year
- PRTC N/A
- FMAO N/A
- Revenue Next Year
- PRTC N/A
- FMAO $6.16
- P/E Ratio
- PRTC $8.19
- FMAO $11.35
- Revenue Growth
- PRTC 44.98
- FMAO 13.86
- 52 Week Low
- PRTC $13.30
- FMAO $20.88
- 52 Week High
- PRTC $25.00
- FMAO $34.15
- Technical
- Relative Strength Index (RSI)
- PRTC 49.08
- FMAO 46.02
- Support Level
- PRTC $15.21
- FMAO $23.35
- Resistance Level
- PRTC $18.20
- FMAO $26.35
- Average True Range (ATR)
- PRTC 0.54
- FMAO 1.08
- MACD
- PRTC -0.12
- FMAO 0.04
- Stochastic Oscillator
- PRTC 71.92
- FMAO 37.04
About PRTC PureTech Health plc
PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.
About FMAO Farmers & Merchants Bancorp Inc.
Farmers & Merchants Bancorp Inc is a holding company based in Ohio. The company is engaged in general commercial banking business. The activities of the company include commercial, agricultural and residential mortgages as well as consumer and credit card lending activities.